Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer’s insomnia treatment hit by ruling

May 24, 2006
Sales and Marketing

A new insomnia treatment developed by Pfizer and Neurocrine Biosciences has suffered a setback after US regulators said a high-dose …

News

Phytopharm looks for licensing partner for Alzheimer drug

May 24, 2006
Research and Development

Specialist pharma company Phytopharm says it is confident of finding a partner to develop and market one of its lead …

News

Exelon is first drug for Parkinson’s disease dementia

May 24, 2006
Research and Development

Exelon has been launched as the first ever treatment for mild to moderately severe dementia associated with idiopathic Parkinson's disease.The …

News

PCTs hiding behind NICE decision over drug, says blindness charity

May 22, 2006

A UK blindness charity says patients are being denied a new drug because PCTs are exploiting a delay in NICE's …

News

Medicom expands into branding

May 19, 2006
Business Services

PR and medical education group Medicom has launched a new consultancy that offers product and corporate branding services.The new division, …

News

Industry experts to advise Northwick Park investigation

May 19, 2006
Research and Development

Experts from the UK's pharmaceutical and biotech industries are to assist the inquiry into the Northwick Park drug trial, which …

News

AstraZeneca’s

May 18, 2006
Research and Development, Sales and Marketing

AstraZeneca is to buy Cambridge Antibody Technology for 702 million pounds in a bid to expand its reach into biotechnology.Cambridge …

News

Seroxat raises suicide risk in young adults, says GSK

May 17, 2006
Sales and Marketing

GlaxoSmithKline says new analyses of its antidepressant Seroxat show the drug raises the risk of suicidal behaviour in young adults.The …

News

Blair speaks out against animal extremists

May 15, 2006
Sales and Marketing

Prime Minister Tony Blair has spoken out against animal rights activists, saying it was time for the 'silent majority' to …

News

UK government declares ‘end to Prozac nation’

May 12, 2006
Sales and Marketing

People suffering from depression in the UK have been promised easier access to counselling and 'talking therapies' by the government, …

News

Pfizer’s smoking cessation drug approved

May 12, 2006
Sales and Marketing

Chantix, a new drug which could help smoker's kick their habit and boost Pfizer's sales by billions has been approved …

News

Kendle spends $215 million to become major clinical research player

May 12, 2006
Research and Development

Kendle is to spend $215 million on buying the business of rivals Charles River, a move which the companys leaders …

News

Merck buys antibody design specialists

May 10, 2006
Research and Development

Merck is to buy a pioneering biotech company, which discovers new monoclonal antibodies and then re-engineers them to make them …

News

Scotland clears Femara for early breast cancer

May 9, 2006
Sales and Marketing

Femara has been recommended for use in Scotland to prevent breast cancer returning after surgery, prompting its manufacturers and stakeholders …

News

Janssen-Cilag submits new schizophrenia drug

May 8, 2006
Sales and Marketing

A new slow-release drug for schizophrenia has been filed for approval in Europe by Jannsen-Cilag, the manufacturers of top-selling Risperdal.Paliperidone …

News

Sanofi profits jump in first quarter

May 5, 2006
Sales and Marketing

Sanofi-Aventis has recorded a major increase in its profits in the first three months of 2006, boosted by product growth …

News

AstraZeneca abandons diabetes drug over safety concerns

May 5, 2006
Research and Development AstraZeneca, PPAR agonist

 AstraZeneca is to abandon its late-stage diabetes drug Galida after new results raised doubts about its safety.Galida is a PPAR …

News

Frontline NHS staff enlisted in fight against flab

May 5, 2006

The nation's increasing weight is to become top priority for frontline NHS staff in an effort to halt the rise …

News

AstraZeneca to co-market nanotechnology cancer drug

May 4, 2006
Sales and Marketing

Groundbreaking nanotechnology is behind a new drug, which AstraZeneca and co-marketers Abraxis BioScience believe could be a major advance in …

News

Project management: from apprentice to master

May 3, 2006
Research and Development, Sales and Marketing

When the three 'Apprentices' enter Mr. Sugars boardroom to explain why they made such a hash of their latest project, …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026